Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32.

Journal of Allergy and Clinical Immunology（2018）

引用 81|浏览37

暂无评分

摘要

Injections of BM32 induced allergen-specific IgG, improved clinical symptoms of seasonal grass pollen allergy, and were well tolerated.

查看译文

关键词

Allergy,grass pollen allergy,allergen,allergen immunotherapy,recombinant allergen,B-cell epitope–based immunotherapy,efficacy,hypoallergenic,clinical trial,safety

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要